Great Novel Therapeutics Biotech & Medicals (TPEX:7427)

TPEX:7427 Revenue

Great Novel Therapeutics Biotech & Medicals had revenue of 623.00K TWD in the half year ending June 30, 2025, a decrease of -86.92%. This brings the company's revenue in the last twelve months to 1.78M, up 189.59% year-over-year. In the year 2024, Great Novel Therapeutics Biotech & Medicals had annual revenue of 1.69M, down -65.26%.

• Revenue (ttm): 1.78M
• Revenue Growth: +189.59%
• P/S Ratio: 1,211.92
• Revenue / Employee: 80.33K
• Employees: 15
• Market Cap: 1.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.69M	-3.17M	-65.26%
Dec 31, 2023	4.85M	4.31M	798.15%
Dec 31, 2022	540.00K	-90.00K	-14.29%
Dec 31, 2021	630.00K	-	-
Dec 31, 2020	-	-	-